Clinical Trial Update: Isotretinoin in Preventing Skin Cancer [NA]

View source ↗

Summary

NIAMS sponsored a completed trial evaluating isotretinoin for preventing skin cancer, including melanoma and non-melanoma skin cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-melanoma Skin Cancer

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Melanoma (Skin), Non-melanomatous Skin Cancer | NA | Status: COMPLETED